Safi R. Bahcall
2013
In 2013, Safi R. Bahcall earned a total compensation of $2.3M as Former President and Chief Executive Officer at Synta Pharmaceuticals, a 13% increase compared to previous year.
Compensation breakdown
| Option Awards | $1,780,361 |
|---|---|
| Salary | $516,667 |
| Other | $31,888 |
| Total | $2,328,916 |
Bahcall received $1.8M in option awards, accounting for 76% of the total pay in 2013.
Bahcall also received $516.7K in salary and $31.9K in other compensation.
Rankings
In 2013, Safi R. Bahcall's compensation ranked 3,362nd out of 12,286 executives tracked by ExecPay. In other words, Bahcall earned more than 72.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,362 out of 12,286 | 73rd |
Division Manufacturing | 1,136 out of 4,612 | 75th |
Major group Chemicals And Allied Products | 302 out of 1,462 | 79th |
Industry group Drugs | 206 out of 1,156 | 82nd |
Industry Pharmaceutical Preparations | 170 out of 890 | 81st |
Source: SEC filing on April 30, 2014.
Bahcall's colleagues
We found five more compensation records of executives who worked with Safi R. Bahcall at Synta Pharmaceuticals in 2013.
2013
Sumant Ramachandra
Synta Pharmaceuticals
Former President, Research and Development
2013
Vojo Vukovic
Synta Pharmaceuticals
Chief Medical Officer
2013
Amar Singh
Synta Pharmaceuticals
Former Senior Vice President, Chief Business Officer
2013
Keith Ehrlich
Synta Pharmaceuticals
Chief Financial Officer
2013
Steven Bernitz
Synta Pharmaceuticals